Purple Biotech (PPBT) Research & Development (2014 - 2026)
Purple Biotech (PPBT) reported Research & Development of $1.2 million for Q1 2026, up 61.84% year-over-year from $760000.0 in Q1 2025, and down 32.75% quarter-over-quarter from $1.8 million in Q4 2025.
Purple Biotech (PPBT) Research & Development (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Research & Development data on file, last reported at $1.2 million in Q1 2026.
- Research & Development for Q1 2026 came in at $1.2 million, up 61.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (down 15.29% YoY), and the FY2025 annual result was $3.7 million, down 51.04% from the prior year.
- Research & Development slipped to $1.2 million in Q1 2026 per PPBT's latest filing, from $1.8 million in the prior quarter.
- Over five years, Research & Development peaked at $6.0 million in Q1 2022 and troughed at $458000.0 in Q4 2024.
- A 5-year average of $2.7 million and a median of $2.4 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development sank 91.26% in 2024, then jumped 299.34% in 2025.
- A 5-year view of Research & Development shows it stood at $4.8 million in 2022, then climbed by 8.76% to $5.2 million in 2023, then slumped by 91.26% to $458000.0 in 2024, then jumped by 299.34% to $1.8 million in 2025, then slumped by 32.75% to $1.2 million in 2026.
- Business Quant data shows PPBT's Research & Development at $1.2 million in Q1 2026, $1.8 million in Q4 2025, and $587000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | 553,000.00 |
| Mar 31, 2025 | 760,000.00 |
| Dec 31, 2024 | 458,000.00 |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 3.47 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 3.25 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 2.09 Mn |